Elfving, Pia http://orcid.org/0000-0002-9885-7242
Kononoff, Aulikki http://orcid.org/0000-0002-0211-9238
Huhtakangas, Johanna http://orcid.org/0000-0002-2090-3173
Kautiainen, Hannu http://orcid.org/0000-0003-0786-0858
Savolainen, Elina http://orcid.org/0000-0002-3796-5143
Arstila, Leena http://orcid.org/0000-0002-4956-4398
Barantseva, Julia http://orcid.org/0000-0002-9695-8971
Rannio, Tuomas http://orcid.org/0000-0002-2418-687X
Niinisalo, Helena http://orcid.org/0000-0002-3321-5345
Puolitaival, Antti http://orcid.org/0000-0002-0739-6509
Soininen, Kati http://orcid.org/0000-0002-5072-1231
Kariniemi, Simo http://orcid.org/0000-0001-8355-0531
Oksaranta, Minni http://orcid.org/0000-0001-8849-0128
Kaipiainen-Seppänen, Oili http://orcid.org/0000-0001-5650-2788
Funding for this research was provided by:
Kuopion Yliopistollinen Sairaala
University of Eastern Finland (UEF) including Kuopio University Hospital
Article History
Received: 21 November 2022
Accepted: 27 December 2022
First Online: 11 January 2023
Declarations
:
: There are no financial or other relations that could lead to a conflict of interest. The authors report following financial activities outside the submitted work: MO, TR, HK, OKS and JB have reported no financial relationships. PE has received consultation fee from Astra Zeneca, lecture fee from Abbvie and reimbursement of congress costs from Mylan and Abbvie. AK has received lecture fees from Abbvie. JH has received consultation fee from Abbvie, Amgen, Boehringer Ingelheim and Novartis, lecture fees from Boehringer Ingelheim and reimbursement of congress costs from Abbvie, Medac, Novartis and Pfizer. ES has received reimbursement of congress costs from Abbvie, Novartis, Pfizer, UCB, Janssen and MSD. LA has received reimbursement of congress costs from Orion. HN has received reimbursement of congress costs from Celltrion. AP has received consultation fee from MSD, lecture fees from MSD, Novartis, UCB, Pfizer, Eli Lilly, Amgen, Boehringer Ingelheim, Abbvie, Novo Nordisk, Celgene and reimbursement of congress costs from Janssen. KS has received consultation fee from Abbvie and reimbursement of congress costs from Abbvie, Novartis and Pfizer. SK has received reimbursement of congress costs from Abbvie, UCB and Medac.
: The studies were performed according to the principles of the Declaration of Helsinki and approved by the Ethics Committee of the Kuopio University Hospital (75/2001, 127/2009 and 1689/2019) and the Rheumatism Foundation Hospital (1991).
: All patients included in the studies 2010 and 2020–2021 gave a written consent.